• Parkinson's Specialist Spins Out From Merck Serono's Soon-to-close R&D Operations More...
• Selcia Limited Exploits in-House IP With Demerger Move More...
• Pfizer Inc. (PFE) Terminates License to 3 Products With Acura Pharmaceuticals, Inc. (ACUR)'s Technology More...
• Alnylam Pharmaceuticals (ALNY) Earns $3.2 Million Milestone Payment From GlaxoSmithKline (GSK) in VaxiRNA Collaboration on Flu Vaccine Production More...
• AspenBio Pharma, Inc. Executes Worldwide License Agreement for its Animal Health Assets More...
• Almirall and Quintiles, Inc. (QTRN) Sign Long-Term Commercial UK Partnership More...
• Transgenomic, Inc. (TBIO) and the Medical College of Wisconsin Announce Collaboration to Provide Next-Generation Sequencing Testing More...
• IGI Laboratories, Inc. Names Jason Grenfell-Gardner CEO More...
• Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals (immy) Board of Directors More...
• Insmed Incorporated (INSM) Announces Planned Departure Of Chief Financial Officer More...
• Bioniche Life Sciences Inc. (BNC) Appoints an Independent Chairman of its Board of Directors More...
• Merck & Co., Inc. (MRK) Net Income Declines by 11% to $1,793 Million in Q2 More...
• Amgen (AMGN)'s Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83 More...
• Compugen Ltd. (CGEN) Second Quarter 2012 Conference Call Scheduled for Tuesday, August 7, 2012 at 10:00 AM EDT More...
• Horizon Pharma, Inc. (HZNP) to Host Conference Call and Webcast to Discuss Second Quarter 2012 Financial Results on August 10, 2012 More...
• NPS Pharmaceuticals, Inc. (NPSP) to Report Second Quarter 2012 Financial Results More...
• Icahn Wins Legal Fight Over Forest Laboratories, Inc. (FRX) Books More...
• Johnson & Johnson (JNJ) Wins Risperdal Suit in Pennsylvania, Again More...
• Former Purdue Pharma L.P. Execs Lose Federal Appeal More...
• Progenics Pharmaceuticals, Inc. (PGNX), Salix Pharmaceuticals, Ltd. (SLXP) Hammered on Relistor Rejection More...
• Talon Therapeutics, Inc. (TLON.OB)'s Flower-Powered Cancer Drug Driving Talks, CEO Says More...
• Eisai Inc. (ESALF.PK) and Arena Pharmaceuticals, Inc. (ARNA) Complete Transfer of BELVIQ® (lorcaserin HCl) New Drug Application More...
• Basilea Pharmaceutica (BSLN.SW) Submits European Marketing Authorization Application of Ceftobiprole for the Treatment of Pneumonia More...
• Watson Pharmaceuticals, Inc. (WPI) Confirms Epiduo® Gel Patent Challenge More...
• Novartis AG (NVS) Drug Afinitor Gets EU Nod for Breast Cancer More...
• Abbott Laboratories (ABT)'s HUMIRA® Approved in Europe for Treatment of Non-radiographic Axial Spondyloarthritis (nr-axSpA) More...
• FDA Grants Priority Review for Exelixis, Inc. (EXEL)'s Cabozantinib in Medullary Thyroid Cancer More...
• Eli Lilly and Company (LLY)'s Solanezumab May Fail Pivotal Studies More...
• Gilead Sciences, Inc. (GILD)'s Single Pill Hepatitis C Study Targets 2014 Approval More...
• Auxilium Pharmaceuticals (AUXL) Reports Positive Top-line Data From XIAFLEX Phase IIIb Trial More...
• immatics biotechnologies GmbH Announces Publication of IMA901 Cancer Vaccine Data in Nature Medicine: Immune Response Associates With Longer Survival More...
• Prima Biomed (PRR.AX) to Release Interim CVac Clinical Data More...
• Scientists Discover Possible Antibiotics Alternative, Monash University Study More...
• Curry Compound May Curb Diabetes Risk, University of Nakomnayok Study More...
• Boys' Impulsiveness May Result in Better Math Ability, Say University of Missouri Researchers More...
• High-Carb Diet Tied to Breast Cancer Risk for Some, International Agency for Research on Cancer Study More...
• Cannabis Science Inc. Releases New Photos on the Continual Improvement of Patient Three Who Suffers from Squamous Cell Carcinoma More...
• Agennix AG Announces Notice of Allowance for U.S. Patent Application Covering Use of Talactoferrin Alfa to Treat Non-Small Cell Lung Cancer and Renal Cancer in Combination With Other Treatments More...
0 comments